April 2, 2015 by Chain Drug Review and Chain Drug Review
Business, Leading Headlines, Retail News
![Target Canada to shut down this month Target Canada to shut down this month](https://chaindrugreview.com/app/uploads/2015/04/Target-Canada-pharmacy_featured.jpg)
MINNEAPOLIS — Target Corp. plans wrap up its exit from the Canadian market this month. Target Canada Co. said Thursday that it will complete its inventory liquidation and shut the last of its 133 discount stores to the public on April 12. The Target subsidiary employed about 17,600 people. In addition, Target Canada’s three distribution
April 1, 2015 by Chain Drug Review and Chain Drug Review
Drive Medical, durable medical equipment, Harvey Diamond, Richard Kolodny
Supplier News
PORT WASHINGTON, N.Y. — Drive Medical this week unveiled a pair of acquisitions, Columbia Medical and Park House Healthcare. The durable medical equipment manufacturer announced the Columbia Medical acquisition on Tuesday. Based in Santa Fe Springs, Calif., Columbia makes complex rehabilitation products for children with disabilities, including wheelchairs, aircraft transfer chairs, bath and shower products,
April 1, 2015 by Chain Drug Review and Chain Drug Review
Chain Drug Consortium, Premier Value Alliance
Leading Headlines, Retail News
![Chain Drug Consortium merges with Premier Value Alliance Chain Drug Consortium merges with Premier Value Alliance](https://chaindrugreview.com/app/uploads/2015/04/Rule_Steve_Chain-Drug-Consortium2_featured.jpg)
BOCA RATON, Fla. — The Chain Drug Consortium (CDC) has combined with its Premier Value Alliance LLC private-label subsidiary to form a new organization. The CDC said Wednesday that the new entity will operate as the Chain Drug Consortium LCC and continue to provide members with group purchasing opportunities and its portfolio of pharmacy industry
March 31, 2015 by Chain Drug Review and Chain Drug Review
2015 Private Label Yearbook, drug stores, PLMA, private label, Private Label Manufacturers Association, store brands
Featured Articles, Leading Headlines, Retail News
![Store-brand sales edge up at drug stores Store-brand sales edge up at drug stores](https://chaindrugreview.com/app/uploads/2015/03/Store-brand_Rite-Aid-shelf-shot.jpg)
NEW YORK — Store-brand dollar sales and share at drug stores rose to a new high in 2014, according to the Private Label Manufacturers Association. Private-brand dollar share grew to 16.5% at drug stores last year on total private-label sales of $8.3 billion, PLMA said Tuesday in releasing its 2015 Private Label Yearbook. Dollar volume
March 31, 2015 by Chain Drug Review and Chain Drug Review
amlodipine and valsartan combination tablets, generic version of Exforge, hypertension medication, Novartis, Peter Goldschmidt, Sandoz
Pharmacy, Supplier News
PRINCETON, N.J. — Sandoz Inc. has released amlodipine and valsartan combination tablets, a hypertension medication, in the United States. The company said Tuesday that its product is a generic version of Exforge, made by Novartis. Sandoz will market its combination amlodipine/valsartan tablets in strengths of 5-160 mg, 5-320 mg, 10-160 mg, 10-320 mg, the same
March 31, 2015 by Chain Drug Review and Chain Drug Review
CVS Health, CVS/pharmacy, MinuteClinic, Rush University Medical Center, Troy Brennan, Tucson Medical Center, walk-in medical clinic
Leading Headlines, Retail News
![CVS forms new clinical affiliations in Illinois, Arizona CVS forms new clinical affiliations in Illinois, Arizona](https://chaindrugreview.com/app/uploads/2015/03/MinuteClinic-Oct2014.jpg)
WOONSOCKET, R.I. — CVS Health has entered into clinical affiliations with Rush University Medical Center in Chicago and Tucson Medical Center in Tucson, Ariz., and its Arizona Connected Care accountable care organization. CVS said Tuesday that through the clinical collaborations it will provide prescription and visit information to the health providers via the integration of
March 31, 2015 by Chain Drug Review and Chain Drug Review
Department of Health and Human Services, Health Care Payment Learning and Action Network, Sylvia Burwell
CDR Blog
![Health care: A cautionary tale Health care: A cautionary tale](https://chaindrugreview.com/app/uploads/2015/03/RediClinic-exam-room_featured.jpg)
A column in the metro New York newspaper Newsday illustrates the type of scenario that the Health Care Payment Learning and Action Network, announced last week by the Department of Health and Human Services, is targeting in its efforts to promote health payment models based on the quality and efficacy of care, rather than the
March 30, 2015 by Chain Drug Review and Chain Drug Review
Auspex Pharmaceuticals, Teva Pharmaceutical Industries
Supplier News
JERUSALEM and LA JOLLA, Calif. — Teva Pharmaceutical Industries Ltd. plans to purchase Auspex Pharmaceuticals Inc. in a deal valued at $3.2 billion. Teva said Monday that the agreement will bolster its core central nervous system (CNS) franchise with the addition of Auspex’s portfolio of medicines for people who live with movement disorders. A biopharmaceutical
March 30, 2015 by Chain Drug Review and Chain Drug Review
Nascobal Nasal Spray, Par Specialty Pharmaceuticals
Supplier News
CHESTNUT RIDGE, N.Y. — Par Specialty Pharmaceuticals has launched of Nascobal Nasal Spray, a prescription vitamin B12 supplement, in a single-use device. Available now at retail pharmacies, Nascobald is administered as one spray for one nostril, once a week. Each single-use device delivers one spray of 500 mcg of cyanocobalamin. Unlike the precursor multi-use glass bottle with actuator
March 30, 2015 by Chain Drug Review and Chain Drug Review
Horizon Pharma, Hyperion Therapeutics
Supplier News
DUBLIN, Ireland, and BRISBANE, Calif. — Horizon Pharma plc plans to acquire biopharmaceutical company Hyperion Therapeutics Inc. in a $1.1 billion cash deal. Horizon said Monday that the agreement will increase its number of products from five to seven, notably through the addition of Ravicti and Buphenyl to its orphan business unit. Ravicti and Buphenyl
March 30, 2015 by Chain Drug Review and Chain Drug Review
Eric Schneiderman, GNC Holdings, Herbal Plus, herbal supplements, Michael Archbold, New York Attorney General
Leading Headlines, Retail News
![GNC, New York AG reach accord on supplements probe GNC, New York AG reach accord on supplements probe](https://chaindrugreview.com/app/uploads/2015/03/GNC-dept-in-Rite-Aid.jpg)
PITTSBURGH — GNC Holdings Inc. has reached an agreement with the New York attorney general that restores the full assortment of its Herbal Plus products to all stores in the state. Some of GNC’s Herbal Plus products were part of an investigation of herbal supplements by New York Attorney General Eric Schneiderman, who in early
March 30, 2015 by Chain Drug Review and Chain Drug Review
Catamaran Corp., Larry Renfro, Mark Thierer, Optum, OptumRx, PBM, pharmacy benefit management, Timothy Wicks, UnitedHealth Group
Business, Leading Headlines, Pharmacy, Retail News
![PBMs OptumRx, Catamaran to merge in $12.8 billion deal PBMs OptumRx, Catamaran to merge in $12.8 billion deal](https://chaindrugreview.com/app/uploads/2015/01/pharmacy-2.jpg)
NEW YORK and SCHAUMBURG, Ill. — Reflecting the ongoing consolidation in the pharmacy benefit management (PBM) sector, UnitedHealth Group plans to acquire Catamaran Corp. in a deal valued at $12.8 billion. The companies said Monday that Catamaran would integrated into OptumRx, UnitedHealth’s freestanding pharmacy care services business and part of its Optum health services unit.
March 27, 2015 by Chain Drug Review and Chain Drug Review
slideshow
Featured Articles, Slideshows
![NACDS RxImpact Day an experience for all NACDS RxImpact Day an experience for all](https://chaindrugreview.com/app/uploads/2015/03/slide-03-RxImpact2015.jpg)
WASHINGTON — Scenes from this year’s NACDS RxImpact Day on Capitol Hill convey the high level of enthusiasm for the event among pharmacy advocates and NACDS members as well as lawmakers and other public officials. More than 350 pharmacy advocates from 44 states met with members of Congress. The advocates — including pharmacists, pharmacy executives,
March 27, 2015 by Chain Drug Review and Chain Drug Review
Cunningham Drug Stores, Stewart Smith
Retail News
GROSSE ILE, Mich. — Stewart Smith, a former president of the now-defunct drug chain Cunningham Drug Stores, passed away earlier this month at age 89. His daughter, Alison Hurley, said in an email that Smith died at his home in Grosse Ile, Mich., on March 23. He is survived by his wife of 63 years,